The investment will support the development of the Băneasa Tumor Centre Hospital, Romania's first private hospital dedicated to the integrated treatment of skin and soft tissue cancers.
The Founders and majority Shareholders, Dr. Mihaela Leventer and Claudiu Opran, will continue to manage the company.
"The complexity of operations, the opportunity to introduce this integrated model of medical services in Romania, and the desire to directly contribute to improving the quality of life for Romanians led us to make this major and necessary investment alongside Leventer Medical Group," said Leonard Leca, Lead Shareholder at 7X Partners.
The hospital, slated to open in the fall of 2025, represents an investment north of €25 million.
The project will cover approximately 10,000 sqm and include 6 operating rooms, 76 beds, an outpatient unit with 18 consultation and treatment rooms, imaging and medical oncology departments, as well as a pathology lab. In the second phase, the group plans to expand the surface area to 12,000 sqm and increase capacity to 100 beds.
